US Patent 10668164 Immunogenic glycoprotein conjugates
Patent 10668164 was granted and assigned to Pfizer Limited on June, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10668164 Immunogenic glycoprotein conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
